Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
- PMID: 17618679
- DOI: 10.1016/j.pbb.2007.06.001
Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
Abstract
Activation of 5-HT(2A) receptors is thought to mediate the hallucinogenic effects of LSD. Nevertheless, in a previous report we provided evidence that a delayed temporal phase of the behavioral pharmacology of LSD is mediated by D(2)-like dopamine receptor stimulation. In this study rats were trained to discriminate LSD with either a 30 min preinjection time (LSD-30, N=12) or a 90 min preinjection time (LSD-90, N=13) from saline, using a two-lever, food-reinforced operant conditioning task. We then tested a large number of agonists and antagonists belonging to distinct pharmacological classes in these animals. As anticipated, classical hallucinogens such as psilocin and mescaline substituted only in LSD-30 rats, and not in LSD-90 rats. The dopamine receptor agonists ABT-724, aripiprazole, dihydrexidine, WAY 100635, and SKF 38393, fully or partially mimicked LSD-90, but not LSD-30. The results reported here support and extend our previous conclusion that the delayed temporal effects of LSD are mediated by activation of a dopaminergic system.
Similar articles
-
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.Psychopharmacology (Berl). 2005 Jul;180(3):427-35. doi: 10.1007/s00213-005-2183-9. Epub 2005 Feb 19. Psychopharmacology (Berl). 2005. PMID: 15723230
-
Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.J Pharmacol Exp Ther. 1988 Sep;246(3):866-70. J Pharmacol Exp Ther. 1988. PMID: 2901488
-
Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.Psychopharmacology (Berl). 2002 Oct;164(1):93-107. doi: 10.1007/s00213-002-1141-z. Epub 2002 Jul 19. Psychopharmacology (Berl). 2002. PMID: 12373423
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
-
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Int J Mol Sci. 2016 Nov 23;17(11):1953. doi: 10.3390/ijms17111953. Int J Mol Sci. 2016. PMID: 27886063 Free PMC article. Review.
Cited by
-
Psychedelics.Pharmacol Rev. 2016 Apr;68(2):264-355. doi: 10.1124/pr.115.011478. Pharmacol Rev. 2016. PMID: 26841800 Free PMC article. Review.
-
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.Elife. 2018 Oct 25;7:e35082. doi: 10.7554/eLife.35082. Elife. 2018. PMID: 30355445 Free PMC article. Clinical Trial.
-
Psychedelics and mental health: a population study.PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013. PLoS One. 2013. PMID: 23976938 Free PMC article.
-
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.Psychopharmacology (Berl). 2013 Jan;225(1):75-93. doi: 10.1007/s00213-012-2797-7. Epub 2012 Jul 29. Psychopharmacology (Berl). 2013. PMID: 22842791
-
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.Psychopharmacology (Berl). 2009 Apr;203(2):265-77. doi: 10.1007/s00213-008-1238-0. Epub 2008 Jul 6. Psychopharmacology (Berl). 2009. PMID: 18604600
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
